KarX-EC: Clinical Trials

3 trials of KarX-EC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1

Follow KarX-EC: new trials by email Literature Review of KarX-EC trials Research Report on KarX-EC

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, Explore the Effect of Food After Multiple Doses of Selected Prototypes, and Evaluate Alternative Formulations of KarX and KarXT Following Single and Multiple Ascending Doses
Xanomeline/Trospium Chloride Capsule, Xanomeline Enteric Capsule, Trospium Chloride - Healthy Volunteers
Phase 1RecruitingBristol-Myers Squibb2362025-06-272026-08-17
Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders
KarXT, KarX-EC - Psychiatric Disorders
Phase 1CompletedBristol-Myers Squibb242025-04-292025-08-06
A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Xanomeline With Trospium Chloride Versus KarXT in Healthy Adult and Elderly Participants of Japanese Ethnicity and to Assess the Effect of Omeprazole on the PK of Xanomeline With Trospium Chloride in Healthy Adult Participants
KarXT, KarX-EC, Placebo - Healthy Volunteers
Phase 1CompletedKaruna Therapeutics, Inc., a Bristol Myers Squibb company782024-10-012025-07-04

Conditions studied

Mental Disorders (1)

Sponsors

Bristol-Myers Squibb (2)  ·  Karuna Therapeutics, Inc., a Bristol Myers Squibb company (1)

Countries

United States (2)  ·  United Kingdom (1)